Alogliptin Impurity 45 | CAS 256386-07-9 - Request Quote
Alogliptin Impurity 45
| SZ CAT No: | SZ-A053068 |
| CAS No | 256386-07-9 |
| Mol.F. | C8H5Br2N |
| Mol.Wt. | 274.9 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Alogliptin Impurity 45 is chemically 3-(Dibromomethyl)benzonitrile. Alogliptin Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Alogliptin Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alogliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 256386-07-9
Purchase 256386-07-9
Order 256386-07-9
Enquire 256386-07-9
price of 256386-07-9
256386-07-9 Supplier
256386-07-9 Manufacturer
256386-07-9 Exporter
buy high quality Alogliptin Impurity 45
Purchase Alogliptin Impurity 45
Alogliptin Impurity 45 suppliers
Alogliptin Impurity 45 manufacturers
Alogliptin Impurity 45 price
Order Alogliptin Impurity 45
Enquire Alogliptin Impurity 45
Alogliptin Impurity 45 cost
Alogliptin Impurity 45 Supplier
Alogliptin Impurity 45 Distributor
Alogliptin Impurity 45 for Method Validation
Alogliptin Reference Standard
Alogliptin Impurity 45 for ANDA Filing
Alogliptin Impurity 45 for Forced Degradation Studies
Alogliptin Impurity 45 Identification Standards
Alogliptin Impurity 45 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.